Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie sp. z o.o. świadczy usługi w ramach NFZ (bezpłatne badania, kolonoskopia) oraz prywatnie (usługi ...
Missing: ogip- | Show results with:ogip-
Jan 14, 2020 · Question Is osocimab, a monoclonal antibody against factor XIa, noninferior to enoxaparin for thromboprophylaxis after knee arthroplasty?
Feb 28, 2024 · The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.
Feb 27, 2024 · The primary objective of this study is to evaluate motor function following treatment with HD nusinersen in participants with spinal ...
Feb 28, 2024 · The goal of this clinical study is to see if sacituzumab govitecan-hziy (SG) can improve life spans of people with HR+/HER2- metastatic breast ...
The purpose of this study is to evaluate zilovertamab vedotin with respect to objective response rate and duration of response per Lugano Response Criteria ...
Brief Summary: This study will evaluate the efficacy and safety of astegolimab compared with placebo in participants with chronic obstructive pulmonary disease ...
Szpital Specjalistyczny im. Rydygiera. Krakow, Poland, 31-826. Status. Recruiting. Contact Us: E-mail: clinical-trials-contact@bayer.com. Phone: (+)1-888-84 ...
Mar 25, 2024 · The purpose of the study is to compare the efficacy of talquetamab subcutaneous(ly) (SC) in combination with daratumumab SC and pomalidomide ...
